Delivery Order SPE2DB22D3301-SPE2DB25FZ0CQ
- Not listed
- The Defense Logistics Agency awarded a $16,057.06 delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $10,028.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 9, 2025, with completion expected by September 10, 2025. This non-set-aside contract represents a pharmaceutical supply delivery under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 29, 2025, for Bridion 500 mg/5 mL vials, with a ceiling value of $35,252.62 under firm fixed-price terms. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $6,129.70 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's broader relationship with the federal government. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of the...
- The Defense Logistics Agency awarded a delivery order valued at $5,967.59 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a single delivery of the pharmaceutical product to support federal medical procurement needs. The performance location is identified as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $17,406.92 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials. This competitively awarded, firm fixed-price contract was executed on September 11, 2025, with an ultimate completion date of September 12, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, valued at $13,599.02 under firm fixed price terms. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,692.64 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price, non-set-aside contract with performance to be conducted in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $9,392.29 to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials (5 mL quantity) on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $19,002.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on April 21, 2025, with an ultimate completion date of April 22, 2025. This non-competitive delivery order is being performed in Conshohocken, Pennsylvania, where the prime contractor maintains its corporate headquarters. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0CQDelivery Order
The Defense Logistics Agency awarded a $17,870.71 delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 ml vials on August 27, 2025, with completion targeted for August 28, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's DLA IDC serves as a global pharmaceutical support vehicle enabling the supply of brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order reflects the company's ongoing capability to fulfill federal pharmaceutical procurement requirements through its established relationship with DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.9k | 8/27/25 |